Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Raid Aljumaily
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
171 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Adventhealth Porter
Denver, Colorado, United States
- Adventhealth Littleton
Littleton, Colorado, United States
- Adventhealth Parker
Parker, Colorado, United States
- Mount Sinai Comprehensive Cancer Center at Aventura
Aventura, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Ctca at Southeastern Regional Medical Center
Newnan, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii, United States
- Island Urology
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Queen'S Cancer Cenrer - Pob I
Honolulu, Hawaii, United States
- Queen'S Cancer Center - Kuakini
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- the Cancer Center of Hawaii-Liliha
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii, United States
- Hawaii Cancer Care - Westridge
‘Aiea, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Queen'S Cancer Center - Pearlridge
‘Aiea, Hawaii, United States
- the Cancer Center of Hawaii-Pali Momi
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Saint Mary'S Hospital
Centralia, Illinois, United States
- Jesse Brown Veterans Affairs Medical Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jan 2021
- Primary completion
- 1 Sept 2026
- Completion
- 1 Sept 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 47
- Registry id
- NCT04310020
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.